Oral delivery of taurocholic acid linked heparin–docetaxel conjugates for cancer therapy
Authors:
- NurunnabiNUNurunnabi
- Gerald R. ReeckGRGerald R. Reeck
- Kwang Jae ChoKCKwang Jae Cho
- Yong-Kyu LeeYLYong-Kyu Lee
- 1 August 2013
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 170 (1) , 74-82
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2010–0021427)
- National Research Foundation of Korea
This publication has 32 references indexed in Scilit:
- Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluationInternational Journal of Nanomedicine, 2012
- Folate-Targeted Polymeric Nanoparticle Formulation of Docetaxel Is an Effective Molecularly Targeted Radiosensitizer with Efficacy Dependent on the Timing of RadiotherapyACS Nano, 2011
- Beads made of cyclodextrin and oil for the oral delivery of lipophilic drugs: In vitro studies in simulated gastro-intestinal fluidsInternational Journal of Pharmaceutics, 2011
- Role of the Intestinal Bile Acid Transporters in Bile Acid and Drug Disposition2010
- Bile acid transportersJournal of Lipid Research, 2009
- Targeting bile-acid signalling for metabolic diseasesNature Reviews Drug Discovery, 2008
- Nanoparticles Incorporated in Bilaminated Films: A Smart Drug Delivery System for Oral FormulationsBiomacromolecules, 2007
- The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivativeBiomaterials, 2007
- Synthesis and Biological Properties of Insulin−Deoxycholic Acid Chemical ConjugatesBioconjugate Chemistry, 2005
- Oral cancer treatment: developments in chemotherapy and beyondBritish Journal of Cancer, 2002